The biotech bi-weekly: cell barcoding, compound optimization and the Trillion Cell Atlas

Written by Beatrice Bowlby (Digital Editor)
Cancer research Cell and tissue biology Drug discovery and development Lab design and machinery News Veterinary science

Over the last 2 weeks, the biotech community has been all about collaborations, with partnerships facilitating the evaluation of off-target chemotherapeutic toxicities, the launch of the Trillion Cell Atlas and the advancement of veterinary immunology research. Plus, we gain an insight into what we can expect at the 2026 AACR Annual Meeting (17–22 April; CA, USA) from Ryvu Therapeutics (Kraków, Poland), as well as the lineup for The Society of Laboratory Automation and Screening (SLAS; IL, USA) Innovation AveNEW program at SLAS Europe 2026 Conference and Exhibition (19–21 May; Vienna, Austria). Products Cell barcoding technology for faster drug discovery Biotium...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
  You might also be interested in...